## Abstract Pluripotent stem cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, both hold great promise for the understanding and treatment of disease. They can be used for drug testing, as in vitro models for human disease progression, and for transplantation therapies. Res
Taking stock and planning for the next decade: Realistic prospects for stem cell therapies for the nervous system
✍ Scribed by Evan Y. Snyder; George Q. Daley; Margaret Goodell
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 266 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0360-4012
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In thinking about the practical application of stem cell biology to clinical situations—particularly for the central nervous system (CNS)—it is instructive to remember that the neural stem cell (NSC) field—as a prototype for somatic stem cells in general—emerged as the unanticipated byproduct of investigations by developmental neurobiologists into fundamental aspects of neural determination, commitment, and plasticity. Stem cell behavior is ultimately an expression of developmental principles, an alluring vestige from the more plastic and generative stages of organogenesis. In attempting to apply stem cell biology therapeutically, it is instructive always to bear in mind what role the stem cell plays in development and to what cues it was “designed” to respond in trying to understand the “logic” behind its behavior (both what investigators want to see and what investigators do not want to see). Furthermore, in transplantation paradigms, the interaction between engrafted NSCs and recipient host is a dynamic, complex, ongoing reciprocal interaction where both entities are constantly in flux. In this review, we propose a “roadmap” to the clinic, with a particular emphasis on flagging the “potholes” and “speed bumps” through which we must navigate. Despite the admonitions to be circumspect, we also suggest disease processes that may be within the grasp of proven stem cell properties and might be approachable in the relatively near future. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
in Sweden, where he has been active throughout his career. He initially trained as a neuroanatomist, and became interested in brain regeneration and repair in the early seventies. Together with his close collaborators Ulf Stenevi, Olle Lindvall, Fred Gage (now at the Salk institute in La Jolla, USA)
## Abstract The human umbilical cord is a rich source of autologous stem and progenitor cells. Interestingly, subpopulations of these, particularly mesenchymal‐like cells from both cord blood and the cord stroma, exhibited a potential to be differentiated into neuron‐like cells in culture. Umbilica